Early responses to chemotherapy of normal and malignant hematologic cells are prognostic in children with acute lymphoblastic leukemia

Journal of Clinical Oncology

Volumn 23, Issue 10, 2005, Pages 2264-2271

  Laughton, Stephen J ^a   Ashton, Lesley J ^a   Kwan, Edward ^a   Norris, Murray D ^a   Haber, Michelle ^a   Marshall, Glenn M ^a  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ARABINOFURANOSIDASE; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOSINE; DAUNORUBICIN; METHOTREXATE; PREDNISOLONE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RISK; CHILD; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IN VIVO STUDY; LYMPHOBLAST; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; NEUTROPHIL COUNT; PRIORITY JOURNAL; ACUTE LYMPHOCYTIC LEUKEMIA; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; INFANT; MULTIVARIATE ANALYSIS; NEUTROPENIA; PATHOLOGY; PREDICTION AND FORECASTING; PRESCHOOL CHILD; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MULTIVARIATE ANALYSIS; NEOPLASM, RESIDUAL; NEUTROPENIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 17144372604     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.012     Document Type: Article

References (26)

1. Rivera GK, Pinkel D, Simone JV, et al: Treatment of acute lymphoblastic leukemia: 30 years' experience at St Jude Children's Research Hospital. N Engl J Med 329:1289-1295, 1993
2. Pui CH, Evans WE: Acute lymphoblastic leukemia. N Engl J Med 339:605-615, 1998
3. Smith M, Arthur D, Camilla B, et al: Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 14:18-24, 1996
4. Pui CH, Crist WM: Biology and treatment of acute lymphoblastic leukemia. J Pediatr 124: 491-503, 1994
5. Hammond D, Sather H, Nesbit M, et al: Analysis of prognostic factors in acute lymphoblastic leukemia. Med Pediatr Oncol 14:124-134, 1986
6. Look AT, Roberson PK, Williams DL, et al: Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood 65:1079-1086, 1985
7. Trueworthy R, Shuster J, Look T, et al: Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Oncology Group study. J Clin Oncol 10:606-613, 1992
8. Raimondi SC, Behm FG, Roberson PK, et al: Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). J Clin Oncol 8:1380-1388, 1990
9. Kalwinsky DK, Roberson P, Dahl G, et al: Clinical relevance of lymphoblast biological features in children with acute lymphoblastic leukemia. J Clin Oncol 3:477-484, 1985
10. Lilleyman JS, Hann IM, Stevens RF: The clinical significance of blast cell morphology in childhood lymphoblastic leukaemia. Med Pediatr Oncol 14:144-147, 1986
11. Miller DR, Krailo M, Bleyer WA, et al: Prognostic implications of blast cell morphology in childhood acute lymphoblastic leukemia: A report from the Childrens Cancer Study Group. Cancer Treat Rep 69:1211-1221, 1985
12. Schrappe M, Camitta B, Pui CH, et al: Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia 14:2193-2194, 2000
13. Gajjar A, Ribeiro R, Hancock ML, et al: Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia. Blood 86:1292-1295, 1995
14. Gaynon PS, Bleyer WA, Steinherz PG, et al: Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features. Med Pediatr Oncol 18:273-279, 1990
15. Cave H, van der Werff ten Bosch J, Suciu S, et al: Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia: European Organization for Research and Treatment of Cancer-Childhood Leukemia Cooperative Group. N Engl J Med 339:591-598, 1998
16. van Dongen JJ, Seriu T, Panzer-Grumayer ER, et al: Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 352:1731-1738, 1998
17. Brisco MJ, Condon J, Hughes E, et al: Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet 343:196-200, 1994
18. Coustan-Smith E, Sancho J, Behm FG, et al: Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia. Blood 100:52-58, 2002
19. Sandlund JT, Harrison PL, Rivera G, et al: Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia. Blood 100: 43-47, 2002
20. Schrappe M, Reiter A, Zimmermann M, et al: Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster. Leukemia 14:2205-2222, 2000
21. McLeod HL, Krynetski EY, Belling MV, et al: Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 14:567-572, 2000
22. Waters K: Australian and New Zealand trials in acute lymphoblastic leukaemia of childhood. Int J Pediatr Hematol Oncol 5:187-197, 1998
23. Marshall GM, Haber M, Kwan E, et al: Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia. J Clin Oncol 21:704-709, 2003
24. Kwan E, Morris MD, Zhu L, et al: Simultaneous detection and quantification of minimal residual disease in childhood acute lymphoblastic leukaemia using real-time polymerase chain reaction. Br J Haematol 109:430-434, 2000
25. Reiter A, Schrappe M, Ludwig WD, et al: Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84:3122-3133, 1994
26. Arico M, Basso G, Mandelli F, et al: Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia: The Associazione Italians Ematologia Oncologia Pediatrica (AIEOP). Cancer 75: 1684-1693, 1995